FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced a line of reagents that provide researchers with new solutions for streamlining the process of performing quantitative reverse transcription PCR in RNA-based research. These reagents consist of new formulations and product-line improvements which are expected to provide researchers with a range of workflow solutions to simplify the processing of RNA in research applications such as gene expression and pathogen detection.
